ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.

Hourigan CS, Beugelink L, Othman J, Gui G, Ivey A, Dillon R, Thiede C, Levis MJ, Dillon LW, Wei AH, Tiong IS, Loo S, Döhner K, Arnhardt I, Kowalik A, Potter N, Hwan Kim DD, Preudhomme C, Duployez N, Heuser M, Valk PJM

Open source

DOI: 10.1182/blood.2026033569
Published: 2026 Aug 13
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026033569,
  title = {ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.},
  author = {Hourigan CS and Beugelink L and Othman J and Gui G and Ivey A and Dillon R and Thiede C and Levis MJ and Dillon LW and Wei AH and Tiong IS and Loo S and Döhner K and Arnhardt I and Kowalik A and Potter N and Hwan Kim DD and Preudhomme C and Duployez N and Heuser M and Valk PJM},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2026033569},
  url = {https://doi.org/10.1182/blood.2026033569}
}

RIS

TY  - JOUR
TI  - ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.
AU  - Hourigan CS
AU  - Beugelink L
AU  - Othman J
AU  - Gui G
AU  - Ivey A
AU  - Dillon R
AU  - Thiede C
AU  - Levis MJ
AU  - Dillon LW
AU  - Wei AH
AU  - Tiong IS
AU  - Loo S
AU  - Döhner K
AU  - Arnhardt I
AU  - Kowalik A
AU  - Potter N
AU  - Hwan Kim DD
AU  - Preudhomme C
AU  - Duployez N
AU  - Heuser M
AU  - Valk PJM
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2026033569
UR  - https://doi.org/10.1182/blood.2026033569
ER  -

APA

CS, H., L, B., J, O., G, G., A, I., R, D., C, T., MJ, L., LW, D., AH, W., IS, T., S, L., K, D., I, A., A, K., N, P., DD, H. K., C, P., N, D., M, H., & PJM, V. (2026). ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.. Blood. https://doi.org/10.1182/blood.2026033569

Source records

pubmed · retrieved 2026-09-25T18:33:28.461Z